Anthropic and OpenEvidence are set to provide doctors in approximately 100 low- and middle-income countries with free access to an AI-powered clinical decision support tool, Reuters reports. The list of countries includes Uganda, Angola, Sudan, Haiti, and Mongolia.
Anthropic provides the underlying technology, while OpenEvidence adapts the system to local conditions; many doctors in these regions lack reliable electricity but do have smartphones. OpenEvidence is already free for doctors in the US and Europe, whereas in Africa, the company had previously limited its operations to pilot programs in Rwanda and Botswana.
Just a week earlier, OpenEvidence reached an agreement with Memorial Sloan Kettering, one of the leading cancer centers in the US. The platform will integrate the center’s OncoKB knowledge base, which is used to determine how specific genetic tumor mutations influence treatment choices. In turn, MSK oncologists will gain access to OpenEvidence directly within their electronic health record systems.
More than half of all hematologist-oncologists in the US already use the service. In August alone, US doctors consulted OpenEvidence 42 million times, according to company founder Daniel Nadler.
In September, according to Forbes, OpenEvidence raised $250 million at a $15 billion valuation in a round led by Byers Capital and Andreessen Horowitz. The company’s valuation has more than quadrupled in 14 months; in July 2023, it stood at $3.5 billion.